ALKINDI SPRINKLE (hydrocortisone) oral granules logo
  • Dosing
    • Treatment Challenges
    • Pediatric-specific Strengths
    • Granular Formulation
    • Administration
    • Individual Dosing
    • Stress Dosing
  • Clinical Trials
    • Phase 3 Study
    • Extension Study
    • Bioequivalence Study to HC Tablet
    • Bioequivalence Study to HC Tablet & Injection
    • Fasted/Fed Bioequivalence Study
    • Bioavailability Study
  • Support
  • Resources
  • Prescribing Information
  • Medication Guide & IFU
  • For
    Patients
  • For Healthcare
    Professionals
GET UPDATES >
GET UPDATES >

Site map

  • Dosing
    • Treatment Challenges
    • Pediatric-specific Strengths
    • Granular Formulation
    • Administration
    • Individual Dosing
    • Stress Dosing
  • Clinical Trials
    • Phase 3 Study
    • Extension Study
    • Bioequivalence Study to HC Tablet
    • Bioequivalence Study to HC Tablet & Injection
    • Fasted/Fed Bioequivalence Study
    • Bioavailability Study
  • Support
  • Resources
  • Sign Up
  • Important Safety Information
  • Prescribing Information
  • Medication Guide & IFU
  • For Patients
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Site Map
Eton Pharmaceuticals logoTolmar Pharmaceuticals logo

This site is for US audiences only. © 2022 Eton Pharmaceuticals and Tolmar Pharmaceuticals, Inc. All rights reserved. Eton, ALKINDI SPRINKLE, and Eton Cares are trademarks of Eton Pharmaceuticals. Tolmar and its associated logo are trademarks of the Tolmar Group. All other trademarks are property of their respective owners. 1075-v1

  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Site Map